Liquidia Corporation’s (LQDA) Yutrepia Launch Continues to Outpace the Expectations
Soumya EswaranThu, September 3, 2026 at 5:10 PM GMT+3 2 min read
Summers Value Partners, a boutique investment firm, noted in its Q2 2026 investor update that The Summers Value Fund delivered strong results in the quarter, returning 41.7% net, outperforming the Russell 2000 Index ETF (IWM), which returned 21.4%, and the Russell 2000 Value Index ETF (IWN), which returned 17.1%. The letter can be downloaded here. The Fund experienced its best quarter since inception, achieving profitability on both long and short positions. Favorable market conditions, particularly in small-cap and healthcare stocks, led to attractive investment opportunities. The Fund maintained a cash position of approximately 13%. Also, check the fund's top five holdings to see its best picks in 2026.
In its second-quarter 2026 investor letter, The Summers Value Fund highlighted Liquidia Corporation (NASDAQ:LQDA). Liquidia Corporation (NASDAQ:LQDA) is a biopharmaceutical company, focusing on developing therapies for rare cardiopulmonary diseases. On September 2, 2026, Liquidia Corporation (NASDAQ:LQDA) closed at $69.68 per share. Over the past month, Liquidia Corporation (NASDAQ:LQDA) declined 22.08%, but its shares are up 141.61% over the past year. Liquidia Corporation (NASDAQ:LQDA) has a market capitalization of $6.24 billion.
The Summers Value Fund stated the following regarding Liquidia Corporation (NASDAQ:LQDA) in its Q2 2026 investor letter:
"The largest contributors to the Fund's performance in the second quarter included Liquidia Corporation (NASDAQ:LQDA), Electromed and Avanos Medical. Liquidia's launch of Yutrepia continues to outpace investor expectations, a trend we expect will continue. The litigation overhang should be resolved in the near term; we expect a decision favoring the company, which could unlock further gains."
Liquidia Corporation (NASDAQ:LQDA) is not on our list of the 40 Most Popular Stocks Among Hedge Funds. As per our database, 44 hedge fund portfolios held Liquidia Corporation (NASDAQ:LQDA) at the end of the second quarter, which was 41 in the previous quarter. While we acknowledge the potential of Liquidia Corporation (NASDAQ:LQDA) as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock.
In another article, we discussed Liquidia Corporation (NASDAQ:LQDA) and shared Greenhaven Road Capital's views on the company. In addition, please check out our hedge fund investor letters Q2 2026 page for more investor letters from hedge funds and other leading investors.
READ NEXT: 33 Stocks That Should Double in 3 Years and 15 Stocks That Will Make You Rich in 10 Years.
Disclosure: None. This article is originally published at Insider Monkey.
Yorumlar (0)
Giriş yaparak yorum yazabilirsin.
İlk yorumu sen yaz.